Found: 35
Select item for more details and to access through your institution.
Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.
- Published in:
- Oncogene, 2005, v. 24, n. 14, p. 2330, doi. 10.1038/sj.onc.1208441
- By:
- Publication type:
- Article
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4632, doi. 10.3390/curroncol29070368
- By:
- Publication type:
- Article
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
- Published in:
- Nature Genetics, 2013, v. 45, n. 10, p. 1226, doi. 10.1038/ng.2754
- By:
- Publication type:
- Article
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.
- Published in:
- PLoS Genetics, 2015, v. 11, n. 6, p. 1, doi. 10.1371/journal.pgen.1005262
- By:
- Publication type:
- Article
A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, <i>RTEL1</i>, Underlies Severe Immunodeficiency and Features of Hoyeraal Hreidarsson Syndrome.
- Published in:
- PLoS Genetics, 2013, v. 9, n. 8, p. 1, doi. 10.1371/journal.pgen.1003695
- By:
- Publication type:
- Article
Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies.
- Published in:
- PLoS Genetics, 2013, v. 9, n. 1, p. 1, doi. 10.1371/journal.pgen.1003220
- By:
- Publication type:
- Article
Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.
- Published in:
- NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0050-5
- By:
- Publication type:
- Article
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes.
- Published in:
- Briefings in Bioinformatics, 2016, v. 17, n. 4, p. 672, doi. 10.1093/bib/bbv075
- By:
- Publication type:
- Article
2023 Canadian Urological Association guideline: Genetic testing in prostate cancer.
- Published in:
- Canadian Urological Association Journal, 2023, v. 17, n. 10, p. 314, doi. 10.5489/cuaj.8588
- By:
- Publication type:
- Article
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
- Published in:
- Canadian Urological Association Journal, 2022, v. 16, n. 10, p. 321, doi. 10.5489/cuaj.7954
- By:
- Publication type:
- Article
Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.
- Published in:
- Familial Cancer, 2022, v. 21, n. 3, p. 369, doi. 10.1007/s10689-021-00270-0
- By:
- Publication type:
- Article
Prevalence of <i>HOXB13</i> mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
- Published in:
- Familial Cancer, 2013, v. 12, n. 4, p. 597, doi. 10.1007/s10689-013-9618-y
- By:
- Publication type:
- Article
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.
- Published in:
- 2013
- By:
- Publication type:
- Letter
"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.
- Published in:
- Oncologist, 2022, v. 27, n. 5, p. e393, doi. 10.1093/oncolo/oyac039
- By:
- Publication type:
- Article
Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6507, doi. 10.1002/cam4.3279
- By:
- Publication type:
- Article
Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach.
- Published in:
- Health Expectations, 2023, v. 26, n. 2, p. 774, doi. 10.1111/hex.13702
- By:
- Publication type:
- Article
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.
- Published in:
- Health Expectations, 2020, v. 23, n. 4, p. 884, doi. 10.1111/hex.13062
- By:
- Publication type:
- Article
Assessment of <i>SLX4</i> Mutations in Hereditary Breast Cancers.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066961
- By:
- Publication type:
- Article
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities.
- Published in:
- Journal of Pathology, 2011, v. 225, n. 1, p. 12, doi. 10.1002/path.2941
- By:
- Publication type:
- Article
How to Screen for Hereditary Cancers in General Pathology Practice.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2016, v. 140, n. 9, p. 899, doi. 10.5858/arpa.2015-0457-RA
- By:
- Publication type:
- Article
Great expectations: patients' preferences for clinically significant results from genomic sequencing.
- Published in:
- Human Genetics, 2023, v. 142, n. 4, p. 553, doi. 10.1007/s00439-023-02543-3
- By:
- Publication type:
- Article
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.
- Published in:
- Human Genetics, 2022, v. 141, n. 12, p. 1875, doi. 10.1007/s00439-022-02466-5
- By:
- Publication type:
- Article
Patient and public preferences for being recontacted with updated genomic results: a mixed methods study.
- Published in:
- Human Genetics, 2021, v. 140, n. 12, p. 1695, doi. 10.1007/s00439-021-02366-0
- By:
- Publication type:
- Article
Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.
- Published in:
- Human Genetics, 2021, v. 140, n. 3, p. 493, doi. 10.1007/s00439-020-02220-9
- By:
- Publication type:
- Article
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0024-8
- By:
- Publication type:
- Article
Clinical and cost outcomes following genomics‐informed treatment for advanced cancers.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5131, doi. 10.1002/cam4.4076
- By:
- Publication type:
- Article
Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.
- Published in:
- CMAJ Open, 2020, v. 8, n. 4, p. E637, doi. 10.9778/cmajo.20190167
- By:
- Publication type:
- Article
Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 338, doi. 10.3390/cancers12020338
- By:
- Publication type:
- Article
Genetic Testing in Gastrointestinal Cancers: A Case-Based Approach.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 5, p. 433
- By:
- Publication type:
- Article
Matching methods in precision oncology: An introduction and illustrative example.
- Published in:
- Molecular Genetics & Genomic Medicine, 2021, v. 9, n. 1, p. 1, doi. 10.1002/mgg3.1554
- By:
- Publication type:
- Article
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.
- Published in:
- Molecular Genetics & Genomic Medicine, 2017, v. 5, n. 3, p. 251, doi. 10.1002/mgg3.281
- By:
- Publication type:
- Article
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.
- Published in:
- 2018
- By:
- Publication type:
- Case Study